Free tool
Heavily traded stocks
We cover 105 companies whose typical session turns over more than $10.00M. The median market value in the group is $1.32B. Across the group, the median move over the past trading day is −0.44%. 69% of the 104 with a 200-day average trade above it. Price change over the past year runs from −38.0% to +245.1% across the middle 80 percent of the group, with a median of +45.5%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
105 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +45.87% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| DRUG | Bright Minds Biosciences Inc. | $751.90M | Small cap | +76.73% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.